Fate Therapeutics to Present at Two Upcoming Conferences in March
Mar 01, 2017 21:02 pm UTC| Business
SAN DIEGO, March 01, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today...
Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2016
Mar 01, 2017 21:02 pm UTC| Business
LIVERMORE, Calif., March 01, 2017 -- Performant Financial Corporation (Nasdaq:PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following...
Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2016
Mar 01, 2017 21:02 pm UTC| Business
LIVERMORE, Calif., March 01, 2017 -- Performant Financial Corporation (Nasdaq:PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following...
Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain
Mar 01, 2017 21:02 pm UTC| Business
SANTA BARBARA, Calif., March 01, 2017 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that Vidur Sahney has been appointed Vice President, Operations and Supply Chain, effective...
Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain
Mar 01, 2017 21:02 pm UTC| Business
SANTA BARBARA, Calif., March 01, 2017 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that Vidur Sahney has been appointed Vice President, Operations and Supply Chain, effective...
Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference
Mar 01, 2017 21:02 pm UTC| Business
WEST LAFAYETTE, Ind., March 01, 2017 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that...
Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference
Mar 01, 2017 21:02 pm UTC| Business
WEST LAFAYETTE, Ind., March 01, 2017 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood